Privia Health (PRVA) traded down -1.12 % during a 24 hours period ending at 06:19 PM Central Europe on Tuesday 27th. One Privia Health stock can currently be bought for about USD 21.91 on popular exchanges. Current supply of Privia Health stocks is 128 mn. Privia Health has a current market capitalization of USD 2.9 bn and approximately USD 18.6 mn worth of Privia Health was traded on exchanges in the last 24 hours. Since last month end, Privia Health has traded 11.52 % up. Simple moving average of last 200 days is at USD 22.69. The highest price of past 52 weeks was recorded at USD 28.82 on 07/16/2026. 52 weeks low was at USD 18.92 on 09/24/2026.

Here is how related stocks have performed in the past 24 hours:

  • Simmons First Natl (SFNC) traded up 0.13 % and now trades at USD 23.43. Current market capitalisation for Simmons First Natl is USD 3.4 bn. Current price/earnings ratio for Simmons First Natl is 12.95.

  • Lemonade (LMND) traded up 0.36 % and now trades at USD 45.61. Lemonade has a market capitalisation of USD 3.4 bn.

  • Acadia (ACAD) traded up 0.05 % and now trades at USD 20.16. Acadia has a market capitalisation of USD 3.4 bn. Acadia has a current price to earnings ratio of 8.89. Wall Street Zen has upgraded ACADIA Pharmaceuticals to a “buy” rating, joining several other analysts who have recently moved from hold to buy. The biopharmaceutical company, which focuses on central nervous system and neuropsychiatric treatments, reported a quarterly earnings figure that surpassed expectations, driven by a notable rise in revenue. Institutional investors have increased their stakes, with several funds adding shares during the third quarter, while insiders have sold a portion of their holdings. Analysts maintain a moderate positive outlook for the company, citing its strong product portfolio and continued growth in revenue. The stock’s recent performance has attracted renewed attention from research firms, all of whom now provide a consensus view that favors a positive trajectory for ACADIA’s shares.

  • Amylyx (AMLX) traded down -0.4 % and now trades at USD 27.64. Current market capitalisation for Amylyx is USD 3.4 bn.

  • American States Water (AWR) traded down -0.26 % and now trades at USD 85.15. American States Water has a market capitalisation of USD 3.4 bn. Current price/earnings ratio for American States Water is 23.34.

About Privia Health

The Privia Health Group Inc. is a physician-enablement company that has its operations in Arlington, United States. The mission of this health care sector entity is to develop a physician platform that revolutionizes the healthcare delivery experience for both providers and consumers globally.